Related Experiment Videos
Lithium toxicity induced by triamterene-hydrochlorothiazide
Postgraduate Medical Journal
|November 1, 1980
Summary
Long-term lithium therapy patients experienced severe toxicity after starting a triamterene and hydrochlorothiazide combination for hypertension. This diuretic combination, previously unlinked to lithium issues, can reduce lithium clearance, leading to dangerous levels.
Area of Science:
- Pharmacology
- Nephrology
- Psychiatry
Background:
- Lithium is a common treatment for manic-depressive psychosis.
- Diuretics that deplete sodium and potassium can reduce lithium clearance.
- Concurrent use of lithium with certain diuretics requires careful monitoring.
Observation:
- Two patients on long-term lithium therapy developed severe lithium toxicity.
- The toxicity occurred shortly after initiating a combination of triamterene (50 mg) and hydrochlorothiazide (25 mg) for hypertension.
- The hypertension was mild and asymptomatic.
Findings:
- The combination of triamterene and hydrochlorothiazide precipitated lithium toxicity in these patients.
- This specific diuretic combination has not been previously documented to cause lithium toxicity.
- Reduced lithium clearance is the likely mechanism for the observed toxicity.
Implications:
- Clinicians should exercise caution when prescribing triamterene/hydrochlorothiazide to patients on lithium therapy.
- This case highlights a potential drug interaction not previously recognized.
- Monitoring lithium levels is crucial when initiating or adjusting diuretic therapy in patients receiving lithium.